CANAGLIFLOZIN F-18

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C24H25FO5S
Molecular Weight	443.518
Optical Activity	UNSPECIFIED
Defined Stereocenters	5 / 5
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC1=CC=C(C=C1CC2=CC=C(S2)C3=CC=C([18F])C=C3)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O

InChI

InChIKey=XTNGUQKDFGDXSJ-ILGLIWPDSA-N

InChI=1S/C24H25FO5S/c1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14/h2-10,19,21-24,26-29H,11-12H2,1H3/t19-,21-,22+,23-,24+/m1/s1/i25-1

HIDE SMILES / InChI

Molecular Formula	C24H25FO5S
Molecular Weight	443.518
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	5 / 5
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 18:42:19 GMT 2023` Edited by `admin` on `Sat Dec 16 18:42:19 GMT 2023`
Record UNII	XAR27Q37KR
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CANAGLIFLOZIN F-18

Common Name

English

(18F)CANAGLIFLOZIN

Common Name

English

D-GLUCITOL, 1,5-ANHYDRO-1-C-(3-((5-(4-(FLUORO-18F)PHENYL)-2-THIENYL)METHYL)-4-METHYLPHENYL)-

Systematic Name

English

Code System Code Type Description

FDA UNII

XAR27Q37KR

Created by admin on Sat Dec 16 18:42:20 GMT 2023 , Edited by admin on Sat Dec 16 18:42:20 GMT 2023

PRIMARY

PUBCHEM

90440019

Created by admin on Sat Dec 16 18:42:20 GMT 2023 , Edited by admin on Sat Dec 16 18:42:20 GMT 2023

PRIMARY

CAS

1415906-04-5

Created by admin on Sat Dec 16 18:42:20 GMT 2023 , Edited by admin on Sat Dec 16 18:42:20 GMT 2023

PRIMARY

Related Record Type Details


					6S49DGR869

CANAGLIFLOZIN ANHYDROUS

NON-LABELED -> LABELED

Amount:


					ZHQ2R96QPT

SODIUM/GLUCOSE COTRANSPORTER 2

TARGET->RADIOLIGAND

Amount:

Name	Property Type	Parameters
ORAL BIOAVAILABILITY	PHARMACOKINETIC
Volume of Distribution	PHARMACOKINETIC	AT STEADY-STATE SINGLE INTRAVENOUS ADMINISTRATION
Biological Half-life	PHARMACOKINETIC	SINGLE DOSE ORAL ADMINISTRATION
Tmax	PHARMACOKINETIC	ORAL ADMINISTRATION SINGLE DOSE
Biological Half-life	PHARMACOKINETIC	ORAL ADMINISTRATION SINGLE DOSE